ArticleInternational journal of clinical oncology2013

Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).

Mariangela Massaccesi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.